GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Basilea Pharmaceutica Ltd (XSWX:BSLN) » Definitions » Receivables Turnover

Basilea Pharmaceutica (XSWX:BSLN) Receivables Turnover : 2.15 (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Basilea Pharmaceutica Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Basilea Pharmaceutica's Revenue for the six months ended in Dec. 2023 was CHF72.7 Mil. Basilea Pharmaceutica's average Accounts Receivable for the six months ended in Dec. 2023 was CHF33.8 Mil. Hence, Basilea Pharmaceutica's Receivables Turnover for the six months ended in Dec. 2023 was 2.15.


Basilea Pharmaceutica Receivables Turnover Historical Data

The historical data trend for Basilea Pharmaceutica's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Basilea Pharmaceutica Receivables Turnover Chart

Basilea Pharmaceutica Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.88 17.07 8.80 5.09 5.16

Basilea Pharmaceutica Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.95 3.21 4.09 2.33 2.15

Competitive Comparison of Basilea Pharmaceutica's Receivables Turnover

For the Biotechnology subindustry, Basilea Pharmaceutica's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Basilea Pharmaceutica's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Basilea Pharmaceutica's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Basilea Pharmaceutica's Receivables Turnover falls into.



Basilea Pharmaceutica Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Basilea Pharmaceutica's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Receivables Turnover (A: Dec. 2023 )
=Revenue / Average Total Inventories
=Revenue (A: Dec. 2023 ) / ((Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count )
=157.634 / ((33.152 + 27.891) / 2 )
=157.634 / 30.5215
=5.16

Basilea Pharmaceutica's Receivables Turnover for the quarter that ended in Dec. 2023 is calculated as

Receivables Turnover (Q: Dec. 2023 )
=Revenue / Average Total Inventories
=Revenue (Q: Dec. 2023 ) / ((Accounts Receivable (Q: Jun. 2023 ) + Accounts Receivable (Q: Dec. 2023 )) / count )
=72.729 / ((39.669 + 27.891) / 2 )
=72.729 / 33.78
=2.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Basilea Pharmaceutica  (XSWX:BSLN) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Basilea Pharmaceutica Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Basilea Pharmaceutica's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Basilea Pharmaceutica (XSWX:BSLN) Business Description

Traded in Other Exchanges
Address
Switzerland Innovation Park, Basel Area, Main Campus, Near Basel, Allschwil, CHE, 4058
Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing drugs to meet the needs of patients with severe bacterial and fungal infections. The Company has operating subsidiaries in the United Kingdom and Germany. Geographically company derives revenue from Japan, Ireland, Republic of Korea, USA, Uruguay, Sweden, Canada, Jordan, Switzerland and Other countries.

Basilea Pharmaceutica (XSWX:BSLN) Headlines

No Headlines